Teva Pharmaceutical Industries, Ltd.: all 671 studies
Page 6 of 7. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting ConditionsCompletedNCT00870142Phase 1
- A Study to Investigate the Absorption, Metabolism and Excretion of TalampanelTerminatedNCT00868361Phase 1
- A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting ConditionsCompletedNCT00865943Phase 1
- A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting ConditionsCompletedNCT00865891Phase 1
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting ConditionsCompletedNCT00865852Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCompletedNCT00865839Phase 1
- A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting ConditionsCompletedNCT00865761Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCompletedNCT00865748Phase 1
- A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting ConditionsCompletedNCT00865696Phase 1
- A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting ConditionsCompletedNCT00865657Phase 1
- A Limited Food Effect Study of Gabapentin 800 mg TabletsCompletedNCT00865631Phase 1
- Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult SubjectsCompletedNCT00865605Phase 1
- A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed ConditionsCompletedNCT00865462Phase 1
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCompletedNCT00865436Phase 1
- A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Fasting ConditionsCompletedNCT00865423Phase 1
- A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting ConditionsCompletedNCT00865410Phase 1
- A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting ConditionsCompletedNCT00865384Phase 1
- A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed ConditionsCompletedNCT00865371Phase 1
- The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult SubjectsCompletedNCT00865267Phase 1
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCompletedNCT00865241Phase 1
- A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting ConditionsCompletedNCT00865215Phase 1
- A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting ConditionsCompletedNCT00865111Phase 1
- A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting ConditionsCompletedNCT00865085Phase 1
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting ConditionsCompletedNCT00865072Phase 1
- A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting ConditionsCompletedNCT00865059Phase 1
- Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy VolunteersCompletedNCT00864968Phase 1
- A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed ConditionsCompletedNCT00864890Phase 1
- A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting ConditionsCompletedNCT00864760Phase 1
- A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting ConditionsCompletedNCT00864747Phase 1
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting ConditionsCompletedNCT00864734Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting ConditionsCompletedNCT00864669Phase 1
- A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting ConditionsCompletedNCT00864617Phase 1
- Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy VolunteersCompletedNCT00864604Phase 1
- A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal SystemCompletedNCT00864565Phase 1
- A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting ConditionsCompletedNCT00864526Phase 1
- Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult SubjectsCompletedNCT00864500Phase 1
- A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting ConditionsCompletedNCT00864448Phase 1
- A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting ConditionsCompletedNCT00864435Phase 1
- A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting ConditionsCompletedNCT00864357Phase 1
- A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting ConditionsCompletedNCT00864344Phase 1
- A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting ConditionsCompletedNCT00864305Phase 1
- A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting ConditionsCompletedNCT00864279Phase 1
- The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult SubjectsCompletedNCT00864240Phase 1
- A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed ConditionsCompletedNCT00864162Phase 1
- A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting ConditionsCompletedNCT00864149Phase 1
- A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting ConditionsCompletedNCT00864071Phase 1
- A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting ConditionsCompletedNCT00864058Phase 1
- A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting ConditionsCompletedNCT00864019Phase 1
- A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting ConditionsCompletedNCT00863941Phase 1
- A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on ApplesauceCompletedNCT00863915Phase 1
- A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Non-fasting ConditionsCompletedNCT00863902Phase 1
- A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting ConditionsCompletedNCT00863863Phase 1
- Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory MalignancyCompletedNCT00863850Phase 1
- Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking MethotrexateCompletedNCT00854685Phase 2
- Buspirone Hydrochloride 30mg Tablets, FastingCompletedNCT00840606Phase 1
- Buspirone Hydrochloride 30mg Tablets, Non-FastingCompletedNCT00840398Phase 1
- Sertraline Hydrochloride 100 mg Tablets, FastingCompletedNCT00836849Phase 1
- Sertraline Hydrochloride 100 mg Tablets, FedCompletedNCT00836667Phase 1
- Benazepril HCl 40 mg Tablets, FastingCompletedNCT00836576Phase 1
- Benazepril HCl 40 mg Tablets, FedCompletedNCT00836537Phase 1
- Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting ConditionsCompletedNCT00835393Phase 1
- Pravastatin Sodium 40 mg Tablets Food Challenge StudyCompletedNCT00834847Phase 1
- Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting ConditionsCompletedNCT00834379Phase 1
- Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal WomenCompletedNCT00830414Phase 1
- Risperidone 1 mg Tablet in Healthy Subjects Under Fasting ConditionsCompletedNCT00830349Phase 1
- Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed ConditionsCompletedNCT00829894Phase 1
- Therapy Optimization in Multiple Sclerosis (MS)CompletedNCT00819000
- A Safety Extension Study of DR-OXY-301CompletedNCT00782769Phase 3
- Comparative Study to Evaluate KADIAN and Avinza in Healthy AdultsCompletedNCT00782548Phase 4
- Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease PatientsCompletedNCT00774982Phase 1
- Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to WaterCompletedNCT00768183Phase 1
- Laquinimod Phase IIa Study in Active Crohn's DiseaseCompletedNCT00737932Phase 2
- Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine PeriodCompletedNCT00723983Phase 1
- Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy VolunteersCompletedNCT00720018Phase 1
- Talampanel for Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00696332Phase 2
- A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive BladderCompletedNCT00685113Phase 3
- Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic TumorsCompletedNCT00675350Phase 1
- A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro FertilizationCompletedNCT00615251Phase 3
- Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential ThrombocytosisCompletedNCT00586651Phase 2
- Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®CompletedNCT00546650Phase 1
- One Year Extension Study To Protocol C2/5/TZ:MS-05TerminatedNCT00464958Phase 1/2
- A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-DeficiencyCompletedNCT00455260Phase 1
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
- Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral ContraceptiveCompletedNCT00362479Phase 3
- Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant SpasticityCompletedNCT00358293Phase 1/2
- A Study to Evaluate the Effectiveness, Tolerability and Safety of LaquinimodCompletedNCT00349193Phase 2
- Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil TreatmentCompletedNCT00343811Phase 3
- Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic PainCompletedNCT00343733Phase 3
- Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN TherapyCompletedNCT00336557
- Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHDCompletedNCT00315276Phase 2
- Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)TerminatedNCT00293111Phase 2
- Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's DiseaseCompletedNCT00287170Phase 1/2
- Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)CompletedNCT00287157Phase 1
- A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot FlashesCompletedNCT00272935Phase 3
- Safety and Efficacy of Talampanel in Glioblastoma MultiformeCompletedNCT00267592Phase 2
- Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast CancerStatus unknownNCT00250874Phase 2
- Non-invasive Measures of Distal Lung Disease in AsthmaticsCompletedNCT00250341Phase 4
- Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.Status unknownNCT00244127Phase 2
- Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple MyelomaTerminatedNCT00242827Phase 2
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.CompletedNCT00240032Phase 4
← Teva Pharmaceutical Industries, Ltd. overview and focus areas